Owner Glaxo Group Limited

Inventors Cooke, Jason William Beames; Glover, Bobby Neal; Lawrence, Ronnie Maxwell; Sharp, Matthew Jude; Tymoschenko, Maria Fumiko

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2002253815

PCT Pub. Number WO2002/066418

Priority 01024074 31.01.01 GB

Filing date 17 December 2001

Wipo publication date 4 September 2002

Acceptance publication date 14 July 2005

C07C 227/18 Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton

C07D 498/04 Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07C 229/52 Compounds containing amino and carboxyl groups bound to the same carbon skeleton

C07D 233/26 Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

C07D 213/79 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 307/68 Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07C 257/14 Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines

A61K 031/44 - Non-condensed pyridines

A61K 031/34 - having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide

A61P 007/00 Drugs for disorders of the blood or the extracellular fluid

C07C 233/26 Carboxylic acid amides